A new trading day began on Monday, with Health Catalyst Inc (NASDAQ: HCAT) stock price down -7.46% from the previous day of trading, before settling in for the closing price of $4.29. HCAT’s price has ranged from $3.76 to $9.24 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 14.98% over the past five years. Meanwhile, its annual earnings per share averaged 5.25%. With a float of $66.41 million, this company’s outstanding shares have now reached $70.21 million.
Let’s look at the performance matrix of the company that is accounted for 1500 employees. In terms of profitability, gross margin is 39.22%, operating margin of -19.76%, and the pretax margin is -22.56%.
Health Catalyst Inc (HCAT) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of Health Catalyst Inc is 5.42%, while institutional ownership is 77.22%. The most recent insider transaction that took place on Mar 06 ’25, was worth 62,860. In this transaction General Counsel of this company sold 13,827 shares at a rate of $4.55, taking the stock ownership to the 160,437 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Chief Operating Officer sold 16,902 for $4.52, making the entire transaction worth $76,331. This insider now owns 216,250 shares in total.
Health Catalyst Inc (HCAT) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.50% during the next five years compared to 38.24% growth over the previous five years of trading.
Health Catalyst Inc (NASDAQ: HCAT) Trading Performance Indicators
Here are Health Catalyst Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.42. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.00 in the next quarter and is forecasted to reach 0.43 in one year’s time.
Technical Analysis of Health Catalyst Inc (HCAT)
Health Catalyst Inc (NASDAQ: HCAT) saw its 5-day average volume 1.13 million, a positive change from its year-to-date volume of 0.9 million. As of the previous 9 days, the stock’s Stochastic %D was 33.53%. Additionally, its Average True Range was 0.36.
During the past 100 days, Health Catalyst Inc’s (HCAT) raw stochastic average was set at 3.83%, which indicates a significant decrease from 11.66% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.01% in the past 14 days, which was higher than the 60.86% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.73, while its 200-day Moving Average is $6.99. Nevertheless, the first resistance level for the watch stands at $4.22 in the near term. At $4.48, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.67. If the price goes on to break the first support level at $3.78, it is likely to go to the next support level at $3.59. The third support level lies at $3.34 if the price breaches the second support level.
Health Catalyst Inc (NASDAQ: HCAT) Key Stats
With a market capitalization of 278.74 million, the company has a total of 70,211K Shares Outstanding. Currently, annual sales are 306,580 K while annual income is -69,500 K. The company’s previous quarter sales were 79,610 K while its latest quarter income was -20,670 K.
